Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

195 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-31

Study Completion Date

2020-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The low sodium intake is important for ascites control in liver cirrhosis patients. Therefore, World Health Organization (WHO) recommends reduction of sodium (Na) to 2g/day for adults. The 24-hour urine Na excretion has been regarded as a standard method to estimate the amount of daily dietary sodium intake. However, it is too inconvenient to apply to patients or the general population in practice. For this reason, it has been suggested that a spot urine Na/potassium (K) ratio could be replaced with the 24-hour urine Na excretion. However, the evidence is not sufficient for that. The investigators will evaluate the usefulness of spot urine Na/K ratio to estimate the dietary sodium intake. The investigators will also verify several formulas of estimating the 24-hour Na excretion with spot urine Na, K, Creatinine (Cr).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver Cirrhosis

NCT05389280

Cirrhosis Kidney Injury Sarcopenia +1 more

UNKNOWN

Korean Cohort Study of AKI & HRS in Cirrhosis

NCT03530761

Liver Cirrhosis Acute Kidney Injury Hepatorenal Syndrome

UNKNOWN

Roles of Uremic Toxins in Uremic Sacropenia

NCT03060590

Sarcopenia

COMPLETED

Incidence of Acute Kidney Injury and Mortality in Critically Ill Patients: Urinary Chloride as a Prognostic Marker

NCT05542927

Acute Kidney Injury

UNKNOWN

24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease

NCT05550467

Chronic Kidney Diseases Electrolyte Imbalance

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

● Detailed Description:

1. Measurements: they should be performed for 2 days (the urine collected within 24 hrs)

* 24-hour urine Na, K and Creatinine (patients were instructed to collect all subsequent urine voids over the next 24-hour period including the ﬁrst void of the following day.)
* Spot urine Na, K, Creatinine with the same urine sample in some containers provided to patients. (every urination)
2. Calculation

* Na/K Ratio with spot urine Na, K
* Estimating 24-hour urine Na with spot urine Na, K, Cr by using some formulas.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Cirrhosis Ascites

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Liver cirrhotic patients with ascites diagnosed by imaging study, biopsy or clinically, regardless of taking diuretics.

Exclusion Criteria

* Uncontrolled sepsis or systemic infection.
* Serum Creatinine \>1.5 mg/dL.
* Patients who are being treated for cancers except hepatocellular carcinoma.
* Patients who refuse the examine or are not cooperative.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No